Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

Cabel, an anecdote about damage done with statistical significance.

Some years ago one fella (don't remember who and forgot to save the link) did a study about statistical power and statistical significance in early stage (p2) clinical trials. His conclusion:

Several probably efficacious drugs got short shrift and were abandoned because of too heavy emphasis on p value in small trials. His advice, if I remember, was either run larger trials if you can afford it or relax with p value.

So, there :)